Indication
Hereditary Coproporphyria
3 clinical trials
3 products
Clinical trial
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic PorphyriasStatus: Completed, Estimated PCD: 2019-01-31
Product
PlaceboProduct
GivosiranClinical trial
Acute Porphyrias: Biomarkers for Disease Activity and Response to TreatmentStatus: Active (not recruiting), Estimated PCD: 2025-12-01
Product
HeminClinical trial
Safety and Efficacy of Panhematin™ for Prevention of Acute Attacks of PorphyriaStatus: Terminated, Estimated PCD: 2023-12-27